Filed: 5/14/2026ACC: 0001104659-26-060750
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 85 equity positions with a total reported market value of $168.03M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
85
Positions
$168.03M
Total AUM (reported)
10.92M
Total Shares
Allocation by class
COMMON$168.03M100.0%
Portfolio Concentration
Top 3$61.16M36.4%
4–10$40.49M24.1%
11–25$40.75M24.3%
Rest$25.64M15.3%
Top 3 weight
36.4%
Top 10 weight
60.5%
Voting Authority Distribution
Total shares with voting rights: 10.92M
Sole
Full voting authority
10.92M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other85
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings85
Rows:
Alphabet Inc-Cl C
DFNDShares91.42K
TypeSH
Market value$26.23M
15.61%
Sole
91.42K
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$25.07M
14.92%
Sole
225K
Shared
0.00
None
0.00
Syndax Pharmaceutical, Inc.
DFNDShares422K
TypeSH
Market value$9.86M
5.87%
Sole
422K
Shared
0.00
None
0.00
Bridgebio Pharma, Inc.
DFNDShares90K
TypeSH
Market value$6.68M
3.98%
Sole
90K
Shared
0.00
None
0.00
Protagonist Therapeutics, Inc
DFNDShares63K
TypeSH
Market value$6.64M
3.95%
Sole
63K
Shared
0.00
None
0.00
Xeris Biopharma Holdings, Inc.
DFNDShares1.06M
TypeSH
Market value$6.15M
3.66%
Sole
1.06M
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares19.48K
TypeSH
Market value$5.73M
3.41%
Sole
19.48K
Shared
0.00
None
0.00
Iovance Biotherapeutics, Inc.
DFNDShares1.60M
TypeSH
Market value$5.62M
3.34%
Sole
1.60M
Shared
0.00
None
0.00
LPL Financial Holdings Inc.
DFNDShares16.50K
TypeSH
Market value$4.96M
2.95%
Sole
16.50K
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares93.53K
TypeSH
Market value$4.71M
2.80%
Sole
93.53K
Shared
0.00
None
0.00
Alkermes PLC
DFNDShares120K
TypeSH
Market value$4.24M
2.53%
Sole
120K
Shared
0.00
None
0.00
Travere Therapeutics, Inc.
DFNDShares140.63K
TypeSH
Market value$4.18M
2.49%
Sole
140.63K
Shared
0.00
None
0.00
Cogent Biosciences Inc.
DFNDShares104K
TypeSH
Market value$4.00M
2.38%
Sole
104K
Shared
0.00
None
0.00
Viridian Therapeutics, Inc.
DFNDShares181K
TypeSH
Market value$3.54M
2.11%
Sole
181K
Shared
0.00
None
0.00
Agios Pharmaceutical, Inc.
DFNDShares93.06K
TypeSH
Market value$3.15M
1.87%
Sole
93.06K
Shared
0.00
None
0.00
Relmada Therapeutics, Inc.
DFNDShares439.30K
TypeSH
Market value$3.06M
1.82%
Sole
439.30K
Shared
0.00
None
0.00
TG Therapeutics, Inc.
DFNDShares90K
TypeSH
Market value$2.99M
1.78%
Sole
90K
Shared
0.00
None
0.00
Catalyst Pharmaceuticals, Inc.
DFNDShares120K
TypeSH
Market value$2.97M
1.77%
Sole
120K
Shared
0.00
None
0.00
Arcellx Inc
DFNDShares19.43K
TypeSH
Market value$2.23M
1.33%
Sole
19.43K
Shared
0.00
None
0.00
SPDR S&P Biotech ETF
DFNDShares15K
TypeSH
Market value$1.92M
1.14%
Sole
15K
Shared
0.00
None
0.00
AllianceBernstein Holding L.P.
DFNDShares48K
TypeSH
Market value$1.80M
1.07%
Sole
48K
Shared
0.00
None
0.00
Arcus Biosciences, Inc.
DFNDShares81.24K
TypeSH
Market value$1.75M
1.04%
Sole
81.24K
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares2.67M
TypeSH
Market value$1.68M
1.00%
Sole
2.67M
Shared
0.00
None
0.00
Cybin Inc
DFNDShares350K
TypeSH
Market value$1.68M
1.00%
Sole
350K
Shared
0.00
None
0.00
Cytokinetics, Incorporated
DFNDShares23.64K
TypeSH
Market value$1.56M
0.93%
Sole
23.64K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Alphabet Inc-Cl CDFND | Common | 91.42K | SH | $26.23M 15.61% | 91.42K | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $25.07M 14.92% | 225K | 0.00 | 0.00 |
Syndax Pharmaceutical, Inc.DFND | Common | 422K | SH | $9.86M 5.87% | 422K | 0.00 | 0.00 |
Bridgebio Pharma, Inc.DFND | Common | 90K | SH | $6.68M 3.98% | 90K | 0.00 | 0.00 |
Protagonist Therapeutics, IncDFND | Common | 63K | SH | $6.64M 3.95% | 63K | 0.00 | 0.00 |
Xeris Biopharma Holdings, Inc.DFND | Common | 1.06M | SH | $6.15M 3.66% | 1.06M | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 19.48K | SH | $5.73M 3.41% | 19.48K | 0.00 | 0.00 |
Iovance Biotherapeutics, Inc.DFND | Common | 1.60M | SH | $5.62M 3.34% | 1.60M | 0.00 | 0.00 |
LPL Financial Holdings Inc.DFND | Common | 16.50K | SH | $4.96M 2.95% | 16.50K | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 93.53K | SH | $4.71M 2.80% | 93.53K | 0.00 | 0.00 |
Alkermes PLCDFND | Common | 120K | SH | $4.24M 2.53% | 120K | 0.00 | 0.00 |
Travere Therapeutics, Inc.DFND | Common | 140.63K | SH | $4.18M 2.49% | 140.63K | 0.00 | 0.00 |
Cogent Biosciences Inc.DFND | Common | 104K | SH | $4.00M 2.38% | 104K | 0.00 | 0.00 |
Viridian Therapeutics, Inc.DFND | Common | 181K | SH | $3.54M 2.11% | 181K | 0.00 | 0.00 |
Agios Pharmaceutical, Inc.DFND | Common | 93.06K | SH | $3.15M 1.87% | 93.06K | 0.00 | 0.00 |
Relmada Therapeutics, Inc.DFND | Common | 439.30K | SH | $3.06M 1.82% | 439.30K | 0.00 | 0.00 |
TG Therapeutics, Inc.DFND | Common | 90K | SH | $2.99M 1.78% | 90K | 0.00 | 0.00 |
Catalyst Pharmaceuticals, Inc.DFND | Common | 120K | SH | $2.97M 1.77% | 120K | 0.00 | 0.00 |
Arcellx IncDFND | Common | 19.43K | SH | $2.23M 1.33% | 19.43K | 0.00 | 0.00 |
SPDR S&P Biotech ETFDFND | Common | 15K | SH | $1.92M 1.14% | 15K | 0.00 | 0.00 |
AllianceBernstein Holding L.P.DFND | Common | 48K | SH | $1.80M 1.07% | 48K | 0.00 | 0.00 |
Arcus Biosciences, Inc.DFND | Common | 81.24K | SH | $1.75M 1.04% | 81.24K | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 2.67M | SH | $1.68M 1.00% | 2.67M | 0.00 | 0.00 |
Cybin IncDFND | Common | 350K | SH | $1.68M 1.00% | 350K | 0.00 | 0.00 |
Cytokinetics, IncorporatedDFND | Common | 23.64K | SH | $1.56M 0.93% | 23.64K | 0.00 | 0.00 |
Page 1 of 4